Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.

Hrusak O, de Haas V, Stancikova J, Vakrmanova B, Janotova I, Mejstrikova E, Capek V, Trka J, Zaliova M, Luks A, Bleckmann K, Möricke A, Irving J, Konatkowska B, Alexander TB, Inaba H, Schmiegelow K, Stokley S, Zemanova Z, Moorman AV, Rossi JG, Felice MS, Dalla-Pozza L, Morales J, Dworzak M, Buldini B, Basso G, Campbell M, Cabrera ME, Marinov N, Elitzur S, Izraeli S, Luria D, Feuerstein T, Kolenova A, Svec P, Kreminska O, Rabin KR, Polychronopoulou S, da Costa E, Marquart HV, Kattamis A, Ratei R, Reinhardt D, Choi JK, Schrappe M, Stary J.

Blood. 2018 Jul 19;132(3):264-276. doi: 10.1182/blood-2017-12-821363. Epub 2018 May 2.

PMID:
29720486
2.

Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients).

Jonasova A, Neuwirtova R, Polackova H, Siskova M, Stopka T, Cmunt E, Belickova M, Moudra A, Minarik L, Fuchs O, Michalova K, Zemanova Z.

Leuk Res. 2018 Jun;69:12-17. doi: 10.1016/j.leukres.2018.03.015. Epub 2018 Mar 27.

PMID:
29614393
3.

High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype.

Sarova I, Brezinova J, Zemanova Z, Ransdorfova S, Svobodova K, Izakova S, Pavlistova L, Lizcova L, Berkova A, Skipalova K, Hodanova L, Salek C, Jonasova A, Michalova K.

Leuk Res. 2018 May;68:85-89. doi: 10.1016/j.leukres.2018.03.009. Epub 2018 Mar 19.

PMID:
29574397
4.

Very short DNA segments can be detected and handled by the repair machinery during germline chromothriptic chromosome reassembly.

Slamova Z, Nazaryan-Petersen L, Mehrjouy MM, Drabova J, Hancarova M, Marikova T, Novotna D, Vlckova M, Vlckova Z, Bak M, Zemanova Z, Tommerup N, Sedlacek Z.

Hum Mutat. 2018 May;39(5):709-716. doi: 10.1002/humu.23408. Epub 2018 Feb 20.

PMID:
29405539
5.

Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders.

Polgarova K, Vargova K, Kulvait V, Dusilkova N, Minarik L, Zemanova Z, Pesta M, Jonasova A, Stopka T.

Oncotarget. 2017 Dec 6;8(67):111966-111978. doi: 10.18632/oncotarget.22957. eCollection 2017 Dec 19.

6.

Cellular differentiation of non-transformed intestinal epithelial cells is regulated by Lactobacillus rhamnosus and L. casei strains.

Kolinska J, Zakostelecka M, Zemanova Z, Lisa V, Golias J, Kozakova H, Dvorak B.

Physiol Res. 2018 May 4;67(2):261-273. Epub 2018 Jan 5.

7.

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia.

Vargova K, Pesta M, Obrtlikova P, Dusilkova N, Minarik L, Vargova J, Berkova A, Zemanova Z, Michalova K, Spacek M, Trneny M, Stopka T.

Blood Cancer J. 2017 Jul 21;7(7):e585. doi: 10.1038/bcj.2017.63. No abstract available.

8.

Differential expression of homologous recombination DNA repair genes in the early and advanced stages of myelodysplastic syndrome.

Valka J, Vesela J, Votavova H, Dostalova-Merkerova M, Horakova Z, Campr V, Brezinova J, Zemanova Z, Jonasova A, Cermak J, Belickova M.

Eur J Haematol. 2017 Oct;99(4):323-331. doi: 10.1111/ejh.12920. Epub 2017 Jul 24.

PMID:
28681469
9.

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.

Rasche M, von Neuhoff C, Dworzak M, Bourquin JP, Bradtke J, Göhring G, Escherich G, Fleischhack G, Graf N, Gruhn B, Haas OA, Klingebiel T, Kremens B, Lehrnbecher T, von Stackelberg A, Tchinda J, Zemanova Z, Thiede C, von Neuhoff N, Zimmermann M, Creutzig U, Reinhardt D.

Leukemia. 2017 Dec;31(12):2807-2814. doi: 10.1038/leu.2017.121. Epub 2017 Apr 25.

10.

Acute lymphoblastic leukemia with aleukemic prodrome: preleukemic dynamics and possible mechanisms of immunosurveillance.

Zimmermannova O, Zaliova M, Moorman AV, Al-Shehhi H, Fronkova E, Zemanova Z, Kalina T, Vora A, Stary J, Trka J, Hrusak O, Zuna J.

Haematologica. 2017 Jun;102(6):e225-e228. doi: 10.3324/haematol.2016.161380. Epub 2017 Mar 2. No abstract available.

11.

Rare congenital chromosomal aberration dic(X;Y)(p22.33;p11.32) in a patient with primary myelofibrosis.

Pavlistova L, Izakova S, Zemanova Z, Bartuskova L, Langova M, Malikova P, Michalova K.

Mol Cytogenet. 2016 Aug 31;9(1):67. doi: 10.1186/s13039-016-0276-2. eCollection 2016.

12.

Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups.

Creutzig U, Zimmermann M, Reinhardt D, Rasche M, von Neuhoff C, Alpermann T, Dworzak M, Perglerová K, Zemanova Z, Tchinda J, Bradtke J, Thiede C, Haferlach C.

Cancer. 2016 Dec 15;122(24):3821-3830. doi: 10.1002/cncr.30220. Epub 2016 Aug 16.

13.

Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.

Busek P, Balaziova E, Matrasova I, Hilser M, Tomas R, Syrucek M, Zemanova Z, Krepela E, Belacek J, Sedo A.

Tumour Biol. 2016 Oct;37(10):13961-13971. Epub 2016 Aug 4.

PMID:
27492457
14.

Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.

Klener P, Fronkova E, Berkova A, Jaksa R, Lhotska H, Forsterova K, Soukup J, Kulvait V, Vargova J, Fiser K, Prukova D, Alam M, Calvin Lenyeletse Maswabi B, Michalova K, Zemanova Z, Jancuskova T, Pekova S, Trneny M.

Int J Cancer. 2016 Nov 15;139(10):2252-60. doi: 10.1002/ijc.30263. Epub 2016 Aug 2.

15.

TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.

Belickova M, Vesela J, Jonasova A, Pejsova B, Votavova H, Merkerova MD, Zemanova Z, Brezinova J, Mikulenkova D, Lauermannova M, Valka J, Michalova K, Neuwirtova R, Cermak J.

Oncotarget. 2016 Jun 14;7(24):36266-36279. doi: 10.18632/oncotarget.9200.

16.

Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.

Nováková M, Žaliová M, Suková M, Wlodarski M, Janda A, Froňková E, Campr V, Lejhancová K, Zapletal O, Pospíšilová D, Černá Z, Kuhn T, Švec P, Pelková V, Zemanová Z, Kerndrup G, van den Heuvel-Eibrink M, van der Velden V, Niemeyer C, Kalina T, Trka J, Starý J, Hrušák O, Mejstříková E.

Haematologica. 2016 Jun;101(6):707-16. doi: 10.3324/haematol.2015.137711. Epub 2016 Mar 24.

17.

Primary and recurrent diffuse astrocytomas: genomic profile comparison reveals acquisition of biologically relevant aberrations.

Lhotska H, Zemanova Z, Cechova H, Ransdorfova S, Svobodova K, Kramar F, Krejcik Z, Michalova K.

Mol Cytogenet. 2016 Feb 9;9:13. doi: 10.1186/s13039-016-0222-3. eCollection 2016.

18.

Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.

Svobodova K, Zemanova Z, Lhotska H, Novakova M, Podskalska L, Belickova M, Brezinova J, Sarova I, Izakova S, Lizcova L, Berkova A, Siskova M, Jonasova A, Cermak J, Michalova K.

Leuk Res. 2016 Mar;42:7-12. doi: 10.1016/j.leukres.2016.01.009. Epub 2016 Jan 24.

PMID:
26851439
19.

Molecular cytogenetic analysis of dicentric chromosomes in acute myeloid leukemia.

Sarova I, Brezinova J, Zemanova Z, Ransdorfova S, Izakova S, Svobodova K, Pavlistova L, Berkova A, Cermak J, Jonasova A, Siskova M, Michalova K.

Leuk Res. 2016 Apr;43:51-7. doi: 10.1016/j.leukres.2016.01.001. Epub 2016 Jan 8.

PMID:
26821593
20.

Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene.

Lhotska H, Zemanova Z, Cechova H, Ransdorfova S, Lizcova L, Kramar F, Krejcik Z, Svobodova K, Bystricka D, Hrabal P, Dohnalova A, Michalova K.

Genes Chromosomes Cancer. 2015 Nov;54(11):655-67. doi: 10.1002/gcc.22266. Epub 2015 Aug 25.

PMID:
26303387
21.

[The prospects for children with acute lymphoblastic leukemia of being cured has increased in the Czech Republic in the 21st century to 90% - outcome of the ALL-IC BFM 2002 trial].

Zdráhalová K, Štěrba J, Domanský J, Blažek B, Ptoszková H, Mihál V, Novák Z, Hak J, Procházková D, Černá Z, Timr P, Jabali Y, Sedláček P, Smíšek P, Zemanová Z, Jarošová M, Houdková A, Mejstříková E, Hrušák O, Zuna J, Janotová I, Trka J, Starý J.

Cas Lek Cesk. 2015;154(2):79-89. Czech.

PMID:
25994910
22.

Aberrant expression of the microRNA cluster in 14q32 is associated with del(5q) myelodysplastic syndrome and lenalidomide treatment.

Krejčík Z, Beličková M, Hruštincová A, Kléma J, Zemanová Z, Michalová K, Čermák J, Jonášová A, Dostálová Merkerová M.

Cancer Genet. 2015 Apr;208(4):156-61. doi: 10.1016/j.cancergen.2015.03.003. Epub 2015 Mar 12.

PMID:
25883014
23.

Guidelines for cytogenetic investigations in tumours.

Hastings RJ, Bown N, Tibiletti MG, Debiec-Rychter M, Vanni R, Espinet B, van Roy N, Roberts P, van den Berg-de-Ruiter E, Bernheim A, Schoumans J, Chatters S, Zemanova Z, Stevens-Kroef M, Simons A, Heim S, Salido M, Ylstra B, Betts DR; Tumour Best Practice meeting; Eurogentest.

Eur J Hum Genet. 2016 Jan;24(1):6-13. doi: 10.1038/ejhg.2015.35. Epub 2015 Mar 25. No abstract available.

24.

An unusual case of high hyperdiploid childhood ALL with cryptic BCR/ABL1 rearrangement.

Lizcova L, Zemanova Z, Lhotska H, Zuna J, Hovorkova L, Mejstrikova E, Malinova E, Rabasova J, Raska I, Sramkova L, Stary J, Michalova K.

Mol Cytogenet. 2014 Oct 24;7(1):72. doi: 10.1186/s13039-014-0072-9. eCollection 2014.

25.

Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.

Merkerova MD, Krejcik Z, Belickova M, Hrustincova A, Klema J, Stara E, Zemanova Z, Michalova K, Cermak J, Jonasova A.

Eur J Haematol. 2015 Jul;95(1):35-43. doi: 10.1111/ejh.12458. Epub 2014 Nov 11.

26.

Change in ploidy status from hyperdiploid to near-tetraploid in multiple myeloma associated with bortezomib/lenalidomide resistance.

Pavlistova L, Zemanova Z, Sarova I, Lhotska H, Berkova A, Spicka I, Michalova K.

Cancer Genet. 2014 Jul-Aug;207(7-8):326-31. doi: 10.1016/j.cancergen.2014.06.027. Epub 2014 Jun 27.

PMID:
25178944
27.

Jumping-like translocation-a rare chromosomal rearrangement in a patient with Burkitt lymphoma/leukemia.

Sarova I, Brezinova J, Lhotska H, Berkova A, Ransdorfova S, Zemanova Z, Soukupova J, Michalova K.

Cancer Genet. 2014 May;207(5):221-5. doi: 10.1016/j.cancergen.2014.05.001. Epub 2014 May 10.

PMID:
24957271
28.

[Molecular cytogenetic analysis of chromosomal aberrations in cells of low grade gliomas and its contribution for tumour classification].

Lhotská H, Zemanová Z, Kramář F, Lizcová L, Svobodová K, Ransdorfová S, Bystřická D, Krejčík Z, Hrabal P, Dohnalová A, Kaiser M, Michalová K.

Klin Onkol. 2014;27(3):183-91. Czech.

PMID:
24918277
29.

Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis.

Zemanova Z, Michalova K, Buryova H, Brezinova J, Kostylkova K, Bystricka D, Novakova M, Sarova I, Izakova S, Lizcova L, Ransdorfova S, Krejcik Z, Merkerova MD, Dohnalova A, Siskova M, Jonasova A, Neuwirtova R, Cermak J.

Leuk Res. 2014 May;38(5):537-44. doi: 10.1016/j.leukres.2014.01.012. Epub 2014 Feb 3.

PMID:
24636338
30.

CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage.

Slamova L, Starkova J, Fronkova E, Zaliova M, Reznickova L, van Delft FW, Vodickova E, Volejnikova J, Zemanova Z, Polgarova K, Cario G, Figueroa M, Kalina T, Fiser K, Bourquin JP, Bornhauser B, Dworzak M, Zuna J, Trka J, Stary J, Hrusak O, Mejstrikova E.

Leukemia. 2014 Mar;28(3):609-20. doi: 10.1038/leu.2013.354. Epub 2013 Nov 25.

PMID:
24270736
31.

Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome.

Brezinova J, Sarova I, Buryova H, Markova J, Ransdorfova S, Izakova S, Kostylkova K, Soukupova J, Zemanova Z, Michalova K.

Br J Haematol. 2014 Jan;164(1):153-5. doi: 10.1111/bjh.12586. Epub 2013 Oct 10. No abstract available.

PMID:
24117282
32.

Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia.

Sarova I, Brezinova J, Zemanova Z, Bystricka D, Krejcik Z, Soukup P, Vydra J, Cermak J, Jonasova A, Michalova K.

Genes Chromosomes Cancer. 2013 Jul;52(7):619-35. doi: 10.1002/gcc.22058. Epub 2013 Apr 12.

PMID:
23580398
33.

Rearrangement of 11q13.2 region in two patients with acute myeloid leukemia.

Sárová I, Březinová J, Zemanová Z, Gančarčíková M, Vydra J, Cermák J, Michalová K.

Leuk Res. 2013 Apr;37(4):479. doi: 10.1016/j.leukres.2012.12.015. Epub 2013 Jan 11. No abstract available.

PMID:
23313045
34.

Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and intermediate-1).

Jonasova A, Cermak J, Vondrakova J, Siskova M, Hochova I, Kadlckova E, Cerna O, Sykora M, Vozobulova V, Seifertova N, Michalova K, Zemanova Z, Brezinova J, Belohlavkova P, Kostecka A, Neuwirtova R.

Leuk Res. 2012 Dec;36(12):e222-4. doi: 10.1016/j.leukres.2012.08.002. Epub 2012 Sep 3. No abstract available.

PMID:
22954608
35.

Changes associated with lenalidomide treatment in the gene expression profiles of patients with del(5q).

Belickova M, Cermak J, Dostalova Merkerova M, Vesela J, Krejcik Z, Cechova E, Zemanova Z, Michalova K, Votavova H, Caniga M, Neuwirtova R, Jonasova A.

Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):375-83. doi: 10.1016/j.clml.2012.04.003. Epub 2012 May 18.

PMID:
22608605
36.

Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites.

Bystricka D, Sarova I, Zemanova Z, Brezinova J, Lizcova L, Izakova S, Dostalova Merkerova M, Krejcik Z, Siskova M, Jonasova A, Neuwirtova R, Cerna O, Cermak J, Michalova K.

Leuk Res. 2012 Jun;36(6):e125-7. doi: 10.1016/j.leukres.2012.02.006. Epub 2012 Mar 3. No abstract available.

PMID:
22391389
37.

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.

Ross FM, Avet-Loiseau H, Ameye G, Gutiérrez NC, Liebisch P, O'Connor S, Dalva K, Fabris S, Testi AM, Jarosova M, Hodkinson C, Collin A, Kerndrup G, Kuglik P, Ladon D, Bernasconi P, Maes B, Zemanova Z, Michalova K, Michau L, Neben K, Hermansen NE, Rack K, Rocci A, Protheroe R, Chiecchio L, Poirel HA, Sonneveld P, Nyegaard M, Johnsen HE; European Myeloma Network.

Haematologica. 2012 Aug;97(8):1272-7. Epub 2012 Feb 27.

38.

From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype.

Merkerova MD, Bystricka D, Belickova M, Krejcik Z, Zemanova Z, Polak J, Hajkova H, Brezinova J, Michalova K, Cermak J.

Genes Chromosomes Cancer. 2012 May;51(5):419-28. doi: 10.1002/gcc.21927. Epub 2012 Jan 17.

PMID:
22250017
39.

Mechanism and genotype-phenotype correlation of two proximal 6q deletions characterized using mBAND, FISH, array CGH, and DNA sequencing.

Vlckova M, Trkova M, Zemanova Z, Hancarova M, Novotna D, Raskova D, Puchmajerova A, Drabova J, Zmitkova Z, Tan Y, Sedlacek Z.

Cytogenet Genome Res. 2012;136(1):15-20. doi: 10.1159/000334709. Epub 2011 Dec 8.

PMID:
22156400
40.

Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies.

Brezinova J, Zemanova Z, Bystricka D, Sarova I, Lizcova L, Malinova E, Izakova S, Sajdova J, Sponerova D, Jonasova A, Cermak J, Michalova K.

Leuk Res. 2012 Mar;36(3):e43-5. doi: 10.1016/j.leukres.2011.11.007. Epub 2011 Dec 6. No abstract available.

PMID:
22153775
41.

Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells.

Procházka P, Libra A, Zemanová Z, Hřebačková J, Poljaková J, Hraběta J, Bunček M, Stiborová M, Eckschlager T.

Cancer Sci. 2012 Feb;103(2):334-41. doi: 10.1111/j.1349-7006.2011.02137.x. Epub 2011 Nov 29.

42.

Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.

Nemec P, Zemanova Z, Kuglik P, Michalova K, Tajtlova J, Kaisarova P, Oltova A, Filkova H, Holzerova M, Balcarkova J, Jarosova M, Rabasova J, Hruba M, Spicka I, Gregora E, Adam Z, Scudla V, Maisnar V, Schutzova M, Hajek R; Czech Myeloma Group.

Leuk Lymphoma. 2012 May;53(5):920-7. doi: 10.3109/10428194.2011.634042. Epub 2011 Dec 13.

PMID:
22023516
43.

A novel gene LRP5 on 11q13.2 is rearranged in two patients with acute myeloid leukemia.

Sárová I, Březinová J, Zemanová Z, Gančarčíková M, Vydra J, Cermák J, Michalová K.

Leuk Res. 2011 Nov;35(11):e200-2. doi: 10.1016/j.leukres.2011.07.022. Epub 2011 Aug 6. No abstract available.

PMID:
21821287
44.

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.

Balgobind BV, Hollink IH, Arentsen-Peters ST, Zimmermann M, Harbott J, Beverloo HB, von Bergh AR, Cloos J, Kaspers GJ, de Haas V, Zemanova Z, Stary J, Cayuela JM, Baruchel A, Creutzig U, Reinhardt D, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM.

Haematologica. 2011 Oct;96(10):1478-87. doi: 10.3324/haematol.2010.038976. Epub 2011 Jul 26.

45.

Jumping translocations in bone marrow cells of pediatric patients with hematologic malignancies: a rare cytogenetic phenomenon.

Lizcova L, Zemanova Z, Malinova E, Michalova K, Smisek P, Stary J.

Cancer Genet. 2011 Jun;204(6):348-9. doi: 10.1016/j.cancergen.2011.04.008. No abstract available.

PMID:
21763634
46.

Unusually long survival of a 67-year-old patient with near-tetraploid acute myeloid leukemia m0 without erythroblastic and megakaryocytic dysplasia.

Lemež P, Klamová H, Zemanová Z, Marinov I, Fuchs O, Schwarz J, Březinová J, Provazníková D, Kostečka A, Marková J, Michalová K, Jelínek J.

Acta Haematol. 2011;126(3):129-34. doi: 10.1159/000328199. Epub 2011 Jun 24.

PMID:
21701158
47.

Recurrence of posterior polymorphous corneal dystrophy is caused by the overgrowth of the original diseased host endothelium.

Merjava S, Malinova E, Liskova P, Filipec M, Zemanova Z, Michalova K, Jirsova K.

Histochem Cell Biol. 2011 Jul;136(1):93-101. doi: 10.1007/s00418-011-0830-2. Epub 2011 Jun 22.

PMID:
21695473
48.

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study.

Coenen EA, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A, Beverloo HB, Chang M, Creutzig U, Dworzak MN, Forestier E, Gibson B, Hasle H, Harrison CJ, Heerema NA, Kaspers GJ, Leszl A, Litvinko N, Lo Nigro L, Morimoto A, Perot C, Reinhardt D, Rubnitz JE, Smith FO, Stary J, Stasevich I, Strehl S, Taga T, Tomizawa D, Webb D, Zemanova Z, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM.

Blood. 2011 Jun 30;117(26):7102-11. doi: 10.1182/blood-2010-12-328302. Epub 2011 May 6.

49.

ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia.

Zuna J, Madzo J, Krejci O, Zemanova Z, Kalinova M, Muzikova K, Zapotocky M, Starkova J, Hrusak O, Horak J, Trka J.

Blood. 2011 Jan 6;117(1):368-9; author reply 370-1. doi: 10.1182/blood-2010-09-309070. No abstract available.

50.

Embryotoxicity of mirtazapine: a study using Chick Embryotoxicity Screening Test.

Manakova E, Hubickova L, Kostalova J, Zemanova Z.

Neuro Endocrinol Lett. 2010;31 Suppl 2:8-10.

PMID:
21187830

Supplemental Content

Loading ...
Support Center